孕19-24周联合筛查子痫前期后的拟议临床管理
这项前瞻性观察研究纳入7748例单胎妊娠,在孕19-24周联合母亲特征、病史及MAP、UtA-PI、PlGF、sFlt-1的MoM值计算子痫前期风险并分层。以<32周风险1/100和<36周风险1/300为切点,高危组占0.9%、包含97%的<32周子痫前期;中危组占17.2%、包含46%的32-35周子痫前期;低危组占81.9%。
要点
- 孕19-24周联合筛查可将人群分为高危0.9%、中危17.2%、低危81.9%。
- 高危组包含97%的<32周子痫前期和45%的32-35周子痫前期。
- 中危组额外包含46%的32-35周子痫前期,低危组仅含9%的32-35周子痫前期。
核心结论
- 孕19-24周联合筛查进行子痫前期风险分层,可识别占总体<1%但包含>95%的<32周子痫前期高危组,以及占总体<20%但包含>90%的32-35周子痫前期中危组。
研究设计与样本
- 前瞻性观察研究,纳入孕19-24周接受常规孕期超声检查的单胎妊娠7748例,其中268例(3.5%)后续发生子痫前期。
- 采用竞争风险模型,将母亲特征与病史的先验风险与MAP、UtA-PI、PlGF和sFlt-1的MoM值结合,计算<32周和<36周分娩子痫前期的患者特异性风险。
- 依据风险将人群分为高危、中危和低危组,并采用不同风险切点改变各组比例并评估筛查性能。
- 因<32周分娩子痫前期例数少,除经验性能外还推导了基于模型的性能。
主要发现
- 以<32周子痫前期风险1/100和<36周子痫前期风险1/300为切点,高危、中危、低危组分别占0.9%、17.2%、81.9%。
- 高危组包含97%的<32周子痫前期和45%的32-35周子痫前期。
- 中危组额外包含46%的32-35周子痫前期。
- 低危组仅包含0.03%的<32周子痫前期和9%的32-35周子痫前期。
关键数值与推荐
- <32周分娩子痫前期风险切点为1/100,<36周分娩子痫前期风险切点为1/300。
- 高危组占0.9%,中危组占17.2%,低危组占81.9%。
- 高危组包含97%的<32周子痫前期和45%的32-35周子痫前期。
- 中危组包含46%的32-35周子痫前期,低危组包含0.03%的<32周子痫前期和9%的32-35周子痫前期。
临床怎么用
- 高危组占总体<1%但包含>95%的<32周子痫前期,需在24-31周进行强化监测。
- 中危组占总体<20%但包含>90%的32-35周子痫前期,需在32周重新评估。
局限性
- <32周分娩子痫前期例数少,因此除经验性能外还推导了基于模型的性能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To estimate the patient-specific risk of pre-eclampsia (PE) at 19-24 weeks' gestation by a combination of maternal characteristics and medical history with multiples of the median (MoM) values of mean arterial pressure (MAP), uterine artery pulsatility index (UtA-PI), serum placental growth factor (PlGF) and serum soluble fms-like tyrosine kinase-1 (sFlt-1), and stratify women into high-, intermediate- and low-risk management groups. METHODS: This was a prospective observational study in women attending a second-trimester ultrasound scan at 19-24 weeks as part of routine pregnancy care. Patient-specific risks of delivery with PE < 32 weeks and < 36 weeks' gestation were calculated using the competing-risks model to combine the prior risk from maternal characteristics and medical history with MoM values of MAP, UtA-PI, PlGF and sFlt-1. On the basis of these risks, the population was stratified into high-, intermediate- and low-risk groups. Different risk cut-offs were used to vary the proportion of the population stratified into each risk category and the performance of screening for delivery with PE at < 32 weeks' gestation, at 32-35 weeks and at ≥ 36 weeks was estimated. In addition to empirical performance, we also derived model-based performance because the number of cases of PE delivering < 32 weeks was low. RESULTS: The study population of 7748 singleton pregnancies included 268 (3.5%) that subsequently developed PE. Using a risk cut-off of 1 in 100 for PE delivering < 32 weeks' gestation and a risk cut-off of 1 in 300 for PE delivering < 36 weeks, the proportion of the population stratified into high-, intermediate- and low-risk was 0.9%, 17.2% and 81.9%, respectively. The high-risk group contained 97% of pregnancies with PE < 32 weeks and 45% of those with PE at 32-35 weeks. The intermediate-risk group contained a further 46% of women with PE at 32-35 weeks. The low-risk group contained only 0.03% of pregnancies with PE < 32 weeks and 9% of those with PE at 32-35 weeks. CONCLUSION: Risk stratification of PE by the combined test at 19-24 weeks' gestation can identify, first, a group which constitutes < 1% of the total population and contains > 95% of those that will develop PE < 32 weeks and are in need of intensive monitoring at 24-31 weeks and, second, a group which constitutes < 20% of the total and contains > 90% of those that will develop PE at 32-35 weeks and are in need of reassessment at 32 weeks. Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd.
引用
- Litwinska M, Wright D, Efeturk T, et al. Proposed clinical management of pregnancies after combined screening for pre-eclampsia at 19-24 weeks' gestation. Ultrasound Obstet Gynecol. 2017. PMID: 28133831. doi:10.1002/uog.17418
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。